Pharmacokinetic studies with valproic acid in man

Area of Science:

• Pharmacology
• Analytical Chemistry

Background:

• Valproic acid (DPA) is a widely used antiepileptic drug.
• Accurate therapeutic drug monitoring is crucial for optimizing patient outcomes.
• Simultaneous analysis of multiple antiepileptic drugs can improve clinical efficiency.

Purpose of the Study:

• To develop and validate a gas chromatographic assay for the simultaneous determination of valproic acid (DPA) and ethosuximide.
• To investigate the pharmacokinetic properties and plasma protein binding of DPA.

Main Methods:

• Gas chromatography was employed for the simultaneous quantification of DPA and ethosuximide.
• Plasma protein binding was assessed in healthy volunteers.
• Pharmacokinetic parameters were evaluated in healthy subjects following oral administration of DPA.

Main Results:

• A significant correlation (r = 0.88) was observed between DPA dose and minimal steady-state plasma levels in epileptic patients.
• DPA exhibited high plasma protein binding (approximately 95%).
• Rapid absorption (Tmax: 1-3 hours) and elimination half-lives of 7.9-10 hours were determined for DPA.

Conclusions:

• The developed assay enables simultaneous measurement of DPA and ethosuximide.
• DPA's pharmacokinetic profile suggests potential for significant plasma concentration fluctuations.
• Specialized pharmaceutical formulations may help minimize these fluctuations for improved therapeutic management.